Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Dividends Paid - Common (2024 - 2025)

Cryo Cell International (CCEL) has disclosed Dividends Paid - Common for 2 consecutive years, with $1.2 million as the latest value for Q2 2025.

  • On a quarterly basis, Dividends Paid - Common changed N/A to $1.2 million in Q2 2025 year-over-year; TTM through Nov 2025 was $3.2 million, a 59.92% increase, with the full-year FY2025 number at $3.2 million, up 59.92% from a year prior.
  • Dividends Paid - Common was $1.2 million for Q2 2025 at Cryo Cell International, down from $2.0 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $2.0 million in Q4 2024 to a low of $1.2 million in Q2 2025.